InMed Pharmaceuticals Inc. has obtained shareholder approval for a corporate name change to Mentari Therapeutics, Inc., and completed a share consolidation 1:10 effective November 5, 2026, with its NASDAQ: INM shares continuing to trade.
InMed Pharmaceuticals Inc. has obtained shareholder approval for a corporate name change to Mentari Therapeutics, Inc., and completed a share consolidation 1:10 effective November 5, 2026, with its NASDAQ: INM shares continuing to trade.